Patterns and prognostic significance of cutaneous immune-related adverse events in non-small cell lung cancer

被引：4
作者：
Thompson, Leah L. [1 ,2 ]
Nadelmann, Emily R. [1 ,2 ]
Blum, Amy E. [1 ,2 ]
Yoon, Jaewon [1 ,2 ]
Polyakov, Nicole J. [1 ,2 ]
Kagan, Ruth D. [1 ,2 ]
Gainor, Justin F. [3 ]
Mooradian, Meghan J. [3 ]
Chen, Steven T. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Dept Dermatol, 50 Staniford St, Boston, MA 02114 USA
[2] Harvard Med Sch, 50 Staniford St, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Dept Med, Div Hematol & Oncol, Ctr Canc, Boston, MA 02114 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 147卷
关键词：
ASSOCIATION;
D O I：
10.1016/j.ejca.2021.01.022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13 / 16
页数：4
相关论文
共 50 条
  • [21] Real-World Prevalence and Tolerability of Immune-Related Adverse Events in Older Adults with Non-Small Cell Lung Cancer: A Multi-Institutional Retrospective Study
    Matsukane, Ryosuke
    Oyama, Takahiro
    Tatsuta, Ryosuke
    Kimura, Sakiko
    Hata, Kojiro
    Urata, Shuhei
    Watanabe, Hiroyuki
    [J]. CANCERS, 2024, 16 (11)
  • [22] Prediction of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint inhibitors based on clinical and hematological markers: Real-world evidence
    Xu, Huiru
    Feng, Huijing
    Zhang, Weihong
    Wei, Feng
    Zhou, Li
    Liu, Liang
    Zhao, Yu
    Lv, Yingge
    Shi, Xiuhuan
    Zhang, Junping
    Ren, Xiubao
    [J]. EXPERIMENTAL CELL RESEARCH, 2022, 416 (01)
  • [23] Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study
    Fujimoto, Airi
    Koutake, Yoshimichi
    Hisamatsu, Daisuke
    Ookubo, Noriko
    Yabuuchi, Yurika
    Kamimura, Go
    Kai, Tatsuo
    Kozono, Aki
    Ootsu, Takahiro
    Suzuki, Hiroto
    Matsuo, Keisuke
    Kuwahara, Kimiko
    Oiwane, Yoshita
    Nagata, Yuko
    Tanimoto, Kenya
    Sato, Eri
    Suenaga, Mei
    Uehara, Tomohiro
    Ikari, Akira
    Endo, Satoshi
    Hiraki, Yoichi
    Kawamata, Yosei
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2169 - 2178
  • [24] Clinical characteristics of adrenal insufficiency as an immune-related adverse event in non-small-cell lung cancer
    Ida, Hanae
    Goto, Yasushi
    Sato, Jun
    Kanda, Shintaro
    Shinno, Yuki
    Morita, Ryou
    Murakami, Shuji
    Matsumoto, Yuji
    Yoshida, Tatsuya
    Horinouchi, Hidehito
    Fujiwara, Yutaka
    Yamamoto, Noboru
    Fukuda, Takahiro
    Ohashi, Ken
    Ohe, Yuichiro
    [J]. MEDICAL ONCOLOGY, 2020, 37 (04)
  • [25] Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer
    Raynes, George
    Stares, Mark
    Low, Samantha
    Haron, Dhania
    Sarwar, Hussain
    Abhi, Dhruv
    Barrie, Colin
    Laird, Barry
    Phillips, Iain
    Mackean, Melanie
    [J]. CANCERS, 2023, 15 (23)
  • [26] Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 Inhibitors
    Oyanagi, Jun
    Koh, Yasuhiro
    Sato, Koichi
    Teraoka, Shunsuke
    Tokudome, Nahomi
    Hayata, Atsushi
    Akamatsu, Hiroaki
    Ozawa, Yuichi
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    [J]. CLINICAL LUNG CANCER, 2021, 22 (06) : E833 - E841
  • [27] Prognostic significance of serum sMICA levels in non-small cell lung cancer
    Wang, L. -P.
    Niu, H.
    Xia, Y. -F.
    Han, Y. -L.
    Niu, P.
    Wang, H. -Y.
    Zhou, Q. -L.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (12) : 2226 - 2230
  • [28] Prognostic Significance of Survivin Polymorphisms on Non-small Cell Lung Cancer Survival
    Dai, Juncheng
    Jin, Guangfu
    Dong, Jing
    Chen, Yijiang
    Xu, Lin
    Hu, Zhibin
    Shen, Hongbing
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (11) : 1748 - 1754
  • [29] Impact of thyroid immune-related adverse events on clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with checkpoint inhibitor therapy: A single center study
    Ceric, Sejla
    Ceric, Timur
    Sokolovic, Emir
    Dalac, Jasmina
    Miletic, Dragana
    Marijanovic, Inga
    Mattar, Layan
    Aljic, Amina
    Agic-Bilalagic, Selma
    Sadija, Amera
    Hadziahmetovic, Miran
    Beslija, Semir
    [J]. BIOMOLECULES AND BIOMEDICINE, 2025,
  • [30] The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer
    Coschi, Courtney H.
    Juergens, Rosalyn A.
    [J]. CURRENT ONCOLOGY, 2021, 28 (06) : 4392 - 4407
12345